Leber Hereditary Optic Neuropathy (LHON)
5 clinical trials · Condition
◉ Watch Leber Hereditary Optic Neuropathy (LHON)
| Record | Firm | Date |
|---|---|---|
| Pilot Study of the Efficacy of Nicotinamide (Vitamin B3) in Leber's Hereditary Optic Neuropathy (NCT07258667) | University Hospital, Angers | 2026-04-01 |
| A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation (NCT07406854) | Wuhan Neurophth Biotechnology Limited Company | 2024-09-19 |
| Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations (NCT05820152) | Neurophth Therapeutics Inc | 2023-08-15 |
| Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations (NCT05293626) | Neurophth Therapeutics Inc | 2023-05-22 |
| Leber Hereditary Optic Neuropathy (LHON) Historical Case Record Survey (NCT01892943) | Santhera Pharmaceuticals | 2013-08-01 |
Track Leber Hereditary Optic Neuropathy (LHON) automatically
Every clearance here is in the API, with alerts when new ones post.